This week our journey among leading labs takes us to meet a pioneer of gene silencing. Pino Macino contributed to the birth of RNA interference, a field awarded a Nobel prize in 2006, and teaches cell biology at Sapienza University of Rome. He thinks CRISPR is a great leap forward in understanding the function of genes. Continue reading
Category Archives: Special guest
Is Italy’s agriculture ready for CRISPR?
Genome editing seems tailored for Italian agriculture as DNA can be modified without introducing foreign sequences and without destroying the legal identity of traditional cultivars. CRISPR could help developing plants more resistant to diseases, for example, avoiding at the same time bureaucracy and public perception problems that have slowed the adoption of GMOs. The stakes are high but some hurdles stand in the way. We have interviewed Michele Morgante, geneticist from the University of Udine and President of the Italian Society of Agricultural Genetics. Continue reading
Is CRISPR feminine in Latin languages?

CRISPR is on the lips of every science enthusiast nowadays, but are we correctly using this acronym? How do Latin languages assimilate hitech neologisms from English? Italian, like French and Spanish, virtually lacks the neutral gender. As a result new words referring to inanimate objects is problematic for non-anglosaxon speakers when forming an agreement with articles, pronouns or adjectives. The author of this blog is Italian and uses CRISPR as a feminine noun, am I right? If so, why is “laser” masculine in Latin languages? If the two technologies could switch their gender, would it affect how they are perceived? I asked for an opinion the Accademia della Crusca, which is the leading institute in the field of research on the Italian language. They asked Anna Thornton, from L’Aquila University, to answer these questions. First of all she stresses that there are no infallible rules in grammatical gender assignment, only trends. Continue reading
Can you make a CRISPR Golden Rice?

Golden Rice may be the best agricultural product from the biotech era before CRISPR. Unfortunately it’s caught in the GMOs redtape, and authorizations for commercial growing are still missing 17 years after its invention. This rice engineered to biosynthesize β-carotene could save lives and improve the health of people struggling with vitamin A deficiency in several regions of the world. If policymakers and consumers will give a warmer response to genome editing, in comparison with classic genetic engineering, could CRISPR solve the impasse by allowing the development of a new non-GM Golden Rice? We asked its inventors, Ingo Potrykus and Peter Beyer.
Oldie but goodie. Sanjaya Rajaram speaks out
He does not write pamphlets with easy recipes for a better world. He has spent more time in the fields than captivating audiences. However, it is a symptom of a cultural disease that few people know Sanjaya Rajaram – and many know Vandana Shiva. This former is an Indian agronomist, who won the 2014 World Food Prize, has picked up the torch of Nobel Peace Prize winner Norman Borlaug, father of the Green Revolution who, in the second half of the last century, doubled grain production in much of the globe, as a result of better seeds, irrigation, fertilizers and pesticides. Rajaram has developed 500 new varieties of wheat grown in 51 countries. He came to Italy for the World Food Research and Innovation Forum promoted by the Emilia Romagna region. Continue reading
Six questions for the YouTuber singing CRISPR
The best explanations of CRISPR ever heard in 413 words, or 4 minutes and half of listening, is not an article from a prestigious science journal but a YouTube video where the wonders of the new technique of genetic modification are sung a cappella. We couldn’t not interview the author. Tim Blais was a fresh physics graduate when he turned its science-music into a professional activity by means of crowdfunding. That about CRISPR is probably his best video and has quickly become viral. Continue reading
Editing cancer at IEO

The second leg of the journey among leading labs takes us to the European Institute of Oncology in Milan. CRISPR’s potential is particularly exciting for oncology, as tumors are caused by multiple mutations and the new technique of genome editing is multiplexable, meaning it may target several genes at the same time. IEO scientific co-director Pier Giuseppe Pelicci has shared his enthusiasm with us.
“In our lab we are using CRISPR in 3 broad research areas. In the first area we follow the classic way, by disrupting the genes we want to study in order to understand their functions. CRISPR can do it much better than the previous techniques. It’s fast, very cheap and easy to handle. Before CRISPR we could carry out an experiment every 6 months, after CRISPR we can do one every week. It’s like altering the flow of time.” Continue reading
Targeting Huntington at CattaneoLab
CRISPR is radically changing the way researchers work, by allowing better, faster, and cheaper experiments. This blog will tell, among other things, how leading labs are using the most popular technique for genome editing. Let the dance begin with the Laboratory of Stem Cell Biology and Pharmacology of Neurodegenerative Diseases of the University of Milan (CattaneoLab). The group directed by Elena Cattaneo is busy unveiling the molecular basis of neurodegeneration in Huntington’s disease with the help of CRISPR, as pharmacologist Chiara Zuccato explains.